Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This trial compared tusamitamab ravtansine (SAR408701) to docetaxel to treat non small cell lung cancer.
It was for people with non small cell cancer that has spread to another part of the body.
Recruitment start: 1 December 2022
Recruitment end: 2 January 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jo Evans
Sanofi
Last reviewed: 15 March 2024
CRUK internal database number: 18461
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
